Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$6.85 - $8.87 $68,500 - $88,699
-10,000 Closed
0 $0
Q1 2022

May 18, 2022

SELL
$6.3 - $10.86 $63,000 - $108,600
-10,000 Reduced 50.0%
10,000 $82,000
Q4 2021

Feb 14, 2022

BUY
$9.44 - $12.24 $188,800 - $244,800
20,000 New
20,000 $216,000

Others Institutions Holding AMYT

About Amryt Pharma plc


  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.